HMGB1 and central nervous system cancer: Hong et al. (2019) examined the effects of HMGB1 on the efficacy of oncolytic herpes simplex virus (oHSV), and demonstrated that the use of HMGB1-blocking antibodies increased the survival of glioma-bearing animals.